Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
| Purity | ≥98% |
|---|---|
| Formula | C25H39H7O8 |
| Formula Wt. | 565.63 |
| Synonym | EHIPA. |
| Solubility | Soluble in water (2 mg/mL). |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
Vitamin D, calcitriol prodrug; VDR agonist.
Prodrug of the compound mycophenolic acid.
SERCA inhibitor.
Endogenous opioid peptide; δOR and μOR agonis...
Cathepsin K inhibitor.
Casein kinase 1α/δ/ε inhibitor.
Nucleoside (deoxyguanosine) analog; DNA chain t...
Mycotoxin produced by Penicillum and Aspergillu...
PI3K inhibitor.
Phenylamino pyridine; Abl, c-Kit, PDGFR, PP2A i...
MEK inhibitor.
Nitrogen mustard, DNA alkylator.
Dihydropyridine; L-type Ca2+ channel blocker.
Vitamin A derivative, acetate ester of retinol....
Thienopyridine; P2Y12 antagonist.
ALK and IGF-1R inhibitor.
Synthetic catechol; ER agonist, microtubule pol...
SIRT1/2 inhibitor, indirect p53 activator.
FIASMA, SERT inhibitor, 5-HT and σ1 antagonist...
MEK1/2 inhibitor.